| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 12/16/2009 | EP2133353A1 Novel adenine compound |
| 12/16/2009 | EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 12/16/2009 | EP2133335A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 12/16/2009 | EP2133331A1 5-membered heterocyclic derivative and use thereof for medical purposes |
| 12/16/2009 | EP2133330A1 Atropisomer of pyrrole derivative |
| 12/16/2009 | EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 12/16/2009 | EP2133084A2 Pharmaceutical Formulation Comprising Lanthanum Compounds |
| 12/16/2009 | EP2131854A1 Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity |
| 12/16/2009 | EP1429602B1 Methods for treating disorders using plant extracts |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101601854A Health care spirit |
| 12/16/2009 | CN101601843A Medicament for treating prostatitis |
| 12/16/2009 | CN101601821A Quality control method for shenfukang tablets |
| 12/16/2009 | CN101601819A Preparation method of medicine for curing greasy urine |
| 12/16/2009 | CN101601813A Medicament for treating hypertensive renal damage and preparation method thereof |
| 12/16/2009 | CN101601792A Preparation method of cornus and cistanche medicinal liquor |
| 12/16/2009 | CN101601773A Manufacturing method of tortoise plastron glue tonic wine |
| 12/16/2009 | CN101601757A Preparation method of medicinal liquor for tonifying kidney and improving eyesight |
| 12/16/2009 | CN101601741A Diuretic medicine and preparation method thereof |
| 12/16/2009 | CN101601736A Traditional Chinese medicine for treating puerperal retention urine |
| 12/16/2009 | CN101601733A Preparation method of powder for eliminating five types of stranguria |
| 12/16/2009 | CN101601731A Preparation method of medicine for eliminating various calculi |
| 12/16/2009 | CN101601730A Health care product for preventing genital and urologic diseases and preparation method thereof |
| 12/16/2009 | CN101601723A Preparation method of paste for tonifying liver and kidney |
| 12/16/2009 | CN101601711A Preparation method of soup for curing frequent urination and enuresis |
| 12/16/2009 | CN101601687A Preparation method of disappearance powder for uremi |
| 12/16/2009 | CN101601673A Composition for solid pharmaceutical preparation of solifenacin or salt thereof |
| 12/16/2009 | CN101601468A Preparation method of wolfberry fruit and broomrape tonic wine |
| 12/16/2009 | CN101601466A Preparation method of oral wine for tonifying kidney, strengthening waist and relaxing muscles and tendons |
| 12/16/2009 | CN100569796C Immune modulating peptide |
| 12/16/2009 | CN100569281C Preparation and use of compositions for treating and preventing necrosis |
| 12/16/2009 | CN100569276C Chinese medicine for treating chronic kidney disease |
| 12/16/2009 | CN100569233C Combination capable of preventing prostate gland cancer |
| 12/15/2009 | US7632951 Inhibitors of integrin ανβ6 |
| 12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 12/15/2009 | US7632830 Lactam compounds and pharmaceutical use thereof |
| 12/15/2009 | US7632643 PCA3, PCA3 genes, and methods of use |
| 12/15/2009 | CA2422698C Indoline derivatives and their use as 5-ht2 receptor ligands |
| 12/15/2009 | CA2348445C Compositions for the treatment and prevention of cardiovascular diseases |
| 12/15/2009 | CA2334189C Bridged indenopyrrolocarbazoles |
| 12/15/2009 | CA2333125C Alpha emitting constructs and uses thereof |
| 12/15/2009 | CA2308604C Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/10/2009 | WO2009149288A2 Extracts of cranberry and methods of using thereof |
| 12/10/2009 | WO2009148874A2 Gamma-lactam compounds for promoting bone growth |
| 12/10/2009 | WO2009148566A2 Development of a c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 12/10/2009 | WO2009148163A1 Agent for contracting bladder detrusor muscle and relaxing urethral sphincter muscle |
| 12/10/2009 | WO2009109618A3 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 |
| 12/10/2009 | WO2009109616A3 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40 |
| 12/10/2009 | WO2009109613A3 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 |
| 12/10/2009 | WO2009095163A3 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 12/10/2009 | US20090306183 Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation |
| 12/10/2009 | US20090306093 Method for treating patient having benign prostate hyperplasia |
| 12/10/2009 | US20090306087 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/10/2009 | US20090306069 Azolidinone-vinyl fused-benzene derivatives |
| 12/10/2009 | US20090305991 33 Human Secreted Proteins |
| 12/10/2009 | US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells |
| 12/09/2009 | EP2131198A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 12/09/2009 | EP2130830A1 Muscarinic receptor antagonists |
| 12/09/2009 | EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/09/2009 | EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/09/2009 | EP2130532A1 Method for treating conditions associated with the accumulation of excess extracellular matrix |
| 12/09/2009 | EP2129663A2 Muscarinic receptor antagonists |
| 12/09/2009 | EP2129370A1 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 12/09/2009 | EP1981843B1 Vitamin d analog: nel, methods and uses thereof |
| 12/09/2009 | EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/09/2009 | EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 12/09/2009 | CN101600683A Therapeutic compounds |
| 12/09/2009 | CN101600475A Small compounds that correct protein misfolding and uses thereof |
| 12/09/2009 | CN101600458A Combination therapy of lower urinary tract disorders with a2d ligands and nsaids |
| 12/09/2009 | CN101597337A Conjugate of hydroxyalkyl starch and an active agent |
| 12/09/2009 | CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/09/2009 | CN101597260A Novel muscarinic receptor antagonist and application thereof |
| 12/09/2009 | CN101596308A ITGB4BP and derivates thereof used for preventing and/or treating hypertrophic scar and fibrosis lesion |
| 12/09/2009 | CN101596306A Pharmaceutical formulations for sustained drug delivery |
| 12/09/2009 | CN101596303A Pharmaceutical compound for curing prostatitis and prostate hyperplasia and preparation method and preparation thereof |
| 12/09/2009 | CN101596171A Tamsulosin sustained release tablet and preparation method thereof |
| 12/09/2009 | CN101596170A Trospium chloride slow-release tablet |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100567253C Novel succinate salt of O-demethyl-venlafaxine |
| 12/09/2009 | CN100566737C Chinese medicine soft capsule for treating urinary system diseases and its preparation process |
| 12/09/2009 | CN100566719C Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
| 12/09/2009 | CN100566711C Compound for the treatment of cancer and use thereof |
| 12/08/2009 | US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 12/08/2009 | US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 12/08/2009 | US7629366 Aminoalcohol derivatives |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629362 2-pyridine carboxamide derivatives |
| 12/08/2009 | US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/08/2009 | US7629341 Human ADAM-10 inhibitors |
| 12/08/2009 | US7629337 Chemokine receptor binding heterocyclic compounds |
| 12/08/2009 | US7629318 Immunosuppressant compounds, methods and uses related thereto |
| 12/08/2009 | US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 12/08/2009 | US7629005 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |
| 12/08/2009 | CA2440744C Il-12 expression controlling agent |
| 12/08/2009 | CA2434829C New benzoylguanidine salt |
| 12/08/2009 | CA2419301C Quinazoline derivatives |